RWE leadership Aetion is a global leader in real-world evidence (RWE) technology and analytics with a robust platform and deep domain expertise, presenting a strong opportunity to cross-sell expanded analytics capabilities, regulatory support tools, and data integration services to health care manufacturers and regulators.

AWS and cloud With availability of the Aetion Evidence Platform in AWS Marketplace and the use of cloud technologies like Amazon EC2 and Apache Spark, there is a sales angle to offer scalable cloud-based RWE workflows, data security enhancements, and managed services to customers seeking rapid deployment and compliance.

Regulatory collaboration Past partnerships involving FDA, NEST, and real-world data linkage position Aetion as a trusted partner for payer and regulatory bodies; opportunities exist to propose expanded validation studies, post-market surveillance, and real-world data linking for label expansions and evidence generation programs.

Strategic acquisitions Recent acquisition activity and corporate tie-ins, such as the Datavant deal, suggest a market shift toward integrated data ecosystems; a sales approach could emphasize joint solutions that combine real-world data with clinical trial data, increasing data richness for insights.

Growth and expansion Aetion’s growth trajectory, leadership presence, and expanding product offerings like Aetion Activate and SURF indicate expanding market demand for faster, transparent evidence; opportunities exist to upsell additional modules, activation services, and professional services for regulatory submissions and commercial strategy.